US Stock MarketDetailed Quotes

AVDL Avadel Pharmaceuticals

Watchlist
  • 7.800
  • -0.140-1.76%
Trading Jan 24 13:04 ET
751.62MMarket Cap-10.40P/E (TTM)

Avadel Pharmaceuticals Key Stats

Avadel Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 8 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 53.032M--
--2024/Q4-- / 50.068M--
Nov 12, 20242024/Q350.025M / 48.629M--
Aug 8, 20242024/Q241.504M / 37.579M--
May 8, 20242024/Q127.178M / 25.896M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 53.032M--
--2024/Q4-- / 50.068M--
Nov 12, 20242024/Q350.025M / 48.629M--
Aug 8, 20242024/Q241.504M / 37.579M--
May 8, 20242024/Q127.178M / 25.896M--

Unlock Free Earnings Estimates

Avadel Pharmaceuticals Earnings Reports

Read more

Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Analysis

Analyst Rating

Updated: Jan 13, 2025

Strong Buy

  • Buy

    100.00%
  • Hold

    0.00%
  • Sell

    0.00%

Price Target

No Data